New drug wash aims to spare bladder cancer patients from repeat surgeries

NCT ID NCT06781879

Recruiting now Disease control Sponsor: Jakob Kristian Jakobsen Source: ClinicalTrials.gov ↗

Summary

This study is for people whose early-stage bladder cancer has come back. It compares a new approach—a strong drug wash (chemoablation) directly into the bladder—to the standard surgery (TURBT). The main goal is to see if the drug wash can better prevent the cancer from returning over two years, potentially reducing the need for future surgeries.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Aalborg University Hospital
NOT_YET_RECRUITING

Aalborg, Denmark

Contact Email: •••••@•••••
Aarhus University Hospital
RECRUITING

Aarhus N, 8200, Denmark

Contact Phone: •••-•••-•••• Email: •••••@•••••
Haukeland University Hospital
NOT_YET_RECRUITING

Bergen, Norway

Contact Email: •••••@•••••
Herlev and Gentofte Hospital
RECRUITING

Herlev, Denmark

Contact Email: •••••@•••••
Landspítali University Hospital
NOT_YET_RECRUITING

Reykjavik, Iceland

Contact Email: •••••@•••••
NU Hospital Group
NOT_YET_RECRUITING

Uddevalla, Sweden

Contact Email: •••••@•••••
Vestfold Hospital Trust
NOT_YET_RECRUITING

Tønsberg, Norway

Contact Email: •••••@•••••
Zealand University Hospital, Roskilde
RECRUITING

Roskilde, Denmark

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

NON-MUSCLE INVASIVE BLADDER CANCER